JNJ-42165279

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for JNJ-42165279, covering 2014-04-23 to 2025-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Single and Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of JNJ-42165279 in Healthy Japanese Male Participants [Phase 1]

See pricing